- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Environmentally-Friendly
Global Pharmaceuticals & Biotech Environmentally-Friendly
Results
3230
0 new
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
3,230 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ACAD | US$15.84 | -2.6% | -33.0% | US$2.7b | US$25.11 | PE86x | E41.7% | n/a | ||
688136 | CN¥14.63 | 5.1% | -22.7% | CN¥2.9b | CN¥24.00 | PS2.1x | E99.2% | 0% | ||
688131 | CN¥24.63 | -0.5% | -39.3% | CN¥5.2b | CN¥32.00 | PE50.3x | E41.0% | 0.3% | ||
300404 | CN¥7.51 | 6.4% | -21.2% | CN¥2.8b | CN¥11.74 | PE77.3x | E40.6% | 0.1% | ||
301333 | CN¥40.12 | 3.1% | -44.7% | CN¥3.8b | CN¥55.00 | PE28.5x | E26.7% | 0.5% | ||
300896 | CN¥147.88 | 10.3% | -47.5% | CN¥44.1b | CN¥264.39 | PE22.1x | E22.3% | 0% | ||
688046 | CN¥11.29 | 1.2% | -35.1% | CN¥4.6b | CN¥16.71 | PE29.2x | E24.6% | 0.5% | ||
2315 | HK$6.07 | -8.7% | -56.1% | HK$2.4b | HK$15.00 | PS2.7x | E109.2% | n/a | ||
6990 | HK$178.50 | -4.5% | 123.3% | HK$37.6b | HK$212.83 | PS19.1x | E8.5% | n/a | ||
AETHER | ₹948.70 | -2.6% | -1.2% | ₹129.4b | ₹1,047.50 | PE152.2x | E45.9% | n/a | ||
CONCORDBIO | ₹2,224.85 | 2.0% | 119.2% | ₹232.7b | ₹1,766.50 | PE74.3x | E25.2% | 0.4% | ||
INNOVACAP | ₹761.80 | -5.1% | n/a | ₹43.6b | ₹765.00 | PE41x | E28.8% | n/a | ||
HUMA | US$6.12 | 17.0% | 115.5% | US$624.2m | US$13.17 | PE-5.2x | E66.1% | n/a | ||
MRNS | US$1.90 | 22.6% | -75.7% | US$89.8m | US$6.89 | PS3.5x | E64.6% | n/a | ||
MARI | €9.48 | 18.5% | -76.3% | €14.6m | €63.00 | PS2.2x | E58.2% | n/a | ||
KAN | SEK 1.96 | 1.1% | -62.4% | SEK 237.5m | SEK 3.10 | PB2.9x | E77.1% | n/a | ||
ETON | US$5.75 | 0.5% | 24.5% | US$150.6m | US$8.50 | PS4.7x | E57.6% | n/a | ||
BFRI | US$1.26 | 0% | -86.2% | US$7.2m | US$11.50 | PB0.6x | E70.6% | n/a | ||
MDWD | US$17.28 | -6.7% | 95.7% | US$189.0m | US$29.75 | PS9.3x | E56.2% | n/a | ||
CRMD | US$7.51 | 4.2% | 105.2% | US$407.8m | US$12.50 | PS520.4x | E65.6% | n/a | ||
MDNA | CA$1.96 | -2.5% | 378.0% | CA$153.1m | CA$4.73 | PB6.6x | E57.2% | n/a | ||
CYCC | US$1.03 | 1.0% | -79.2% | US$2.0m | US$11.00 | PS25.4x | E71.5% | n/a | ||
PGEN | US$0.97 | -3.0% | -30.9% | US$277.7m | US$6.00 | PS63.5x | E64.1% | n/a | ||
ATYR | US$1.74 | -5.4% | 9.4% | US$134.2m | US$22.00 | PS224.3x | E67.4% | n/a |